PL338181A1 - Novel chemical compounds - Google Patents

Novel chemical compounds

Info

Publication number
PL338181A1
PL338181A1 PL98338181A PL33818198A PL338181A1 PL 338181 A1 PL338181 A1 PL 338181A1 PL 98338181 A PL98338181 A PL 98338181A PL 33818198 A PL33818198 A PL 33818198A PL 338181 A1 PL338181 A1 PL 338181A1
Authority
PL
Poland
Prior art keywords
pct
chemical compounds
novel chemical
sec
date
Prior art date
Application number
PL98338181A
Other languages
English (en)
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of PL338181A1 publication Critical patent/PL338181A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
PL98338181A 1997-07-22 1998-07-15 Novel chemical compounds PL338181A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702774A SE9702774D0 (sv) 1997-07-22 1997-07-22 Novel compounds
PCT/SE1998/001394 WO1999005144A1 (en) 1997-07-22 1998-07-15 Novel compounds

Publications (1)

Publication Number Publication Date
PL338181A1 true PL338181A1 (en) 2000-10-09

Family

ID=20407805

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98338181A PL338181A1 (en) 1997-07-22 1998-07-15 Novel chemical compounds

Country Status (21)

Country Link
US (1) US6166022A (enExample)
EP (1) EP0998475B1 (enExample)
JP (1) JP2001510843A (enExample)
KR (1) KR20010022084A (enExample)
CN (1) CN1270591A (enExample)
AT (1) ATE216390T1 (enExample)
AU (1) AU8370798A (enExample)
BR (1) BR9811028A (enExample)
CA (1) CA2296426A1 (enExample)
DE (1) DE69804966T2 (enExample)
EE (1) EE200000048A (enExample)
HU (1) HUP0003826A3 (enExample)
ID (1) ID25856A (enExample)
IL (1) IL134111A0 (enExample)
IS (1) IS5352A (enExample)
NO (1) NO20000313L (enExample)
PL (1) PL338181A1 (enExample)
SE (1) SE9702774D0 (enExample)
SK (1) SK188299A3 (enExample)
TR (1) TR200000152T2 (enExample)
WO (1) WO1999005144A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
US6369064B1 (en) * 1998-02-17 2002-04-09 Astrazeneca Ab Triazolo(4,5-d)pyrimidine compounds
CA2380656A1 (en) 1999-09-09 2001-03-15 Nadine Derrien Substituted cyclopentenes, their preparation and their use for chiral scaffolds
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
US7115585B2 (en) * 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
AR039558A1 (es) * 2000-08-21 2005-02-23 Inspire Pharmaceuticals Inc Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7435724B2 (en) * 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
CN1863789B (zh) 2003-10-03 2010-06-09 博尔托拉制药公司 取代的异喹啉酮
CA2540214A1 (en) 2003-10-03 2005-04-14 Portola Pharmaceuticals, Inc. 2,4-dioxo-3-quinazolinylaryl sulfonylureas
EP1685135B1 (en) 2003-10-21 2010-05-26 Inspire Pharmaceuticals, Inc. TETRAHYDRO-FURO[3,4-d]DIOXOLE COMPOUNDS AND COMPOSITIONS AND METHOD FOR INHIBITING PLATELET AGGREGATION
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7749981B2 (en) 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
KR20070064356A (ko) 2004-09-29 2007-06-20 포톨라 파마슈티컬스, 인코포레이티드 치환된 2ｈ-1,3-벤족사진-4(3ｈ)온
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
JPWO2007020935A1 (ja) * 2005-08-17 2009-02-26 小野薬品工業株式会社 Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤
WO2007056219A2 (en) 2005-11-03 2007-05-18 Portola Pharmaceuticals, Inc. [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
JP2010508350A (ja) 2006-10-31 2010-03-18 ヤンセン ファーマシューティカ エヌ．ベー． Ａｄｐｐ２ｙ１２レセプターアンタゴニストとしてのトリアゾロピリミジン誘導体
WO2011133871A2 (en) * 2010-04-22 2011-10-27 Alnylam Pharmaceuticals, Inc. 5'-end derivatives
EP2576553A4 (en) * 2010-05-27 2013-11-20 Reddys Lab Ltd Dr EXTREMELY SELECTIVE ASYMMETRIC HYDROFORMYLATION OF (+) OR (-) - LACTAM (1S, 4R) - OR (1R, 4S) -2-AZABICYCLO [2.2.1] HEPT-5-EN-3-ONE
US9458244B2 (en) 2012-12-28 2016-10-04 Abbvie Inc. Single chain multivalent binding protein compositions and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
WO1994018215A1 (en) * 1993-02-03 1994-08-18 Gensia, Inc. Adenosine kinase inhibitors comprising lyxofuranosyl derivatives
TR199800019T1 (xx) * 1995-07-11 1998-05-21 Astra Pharmaceuticals Limited Trombosit topaklanmas�n� �nleyici yeni maddeler.

Also Published As

Publication number Publication date
DE69804966T2 (de) 2002-11-07
NO20000313L (no) 2000-03-22
EP0998475B1 (en) 2002-04-17
US6166022A (en) 2000-12-26
CA2296426A1 (en) 1999-02-04
CN1270591A (zh) 2000-10-18
EP0998475A1 (en) 2000-05-10
NO20000313D0 (no) 2000-01-21
ID25856A (id) 2000-11-09
EE200000048A (et) 2000-10-16
HUP0003826A3 (en) 2001-11-28
KR20010022084A (ko) 2001-03-15
JP2001510843A (ja) 2001-08-07
SK188299A3 (en) 2000-08-14
IL134111A0 (en) 2001-04-30
DE69804966D1 (de) 2002-05-23
AU8370798A (en) 1999-02-16
HUP0003826A2 (hu) 2001-04-28
ATE216390T1 (de) 2002-05-15
TR200000152T2 (tr) 2000-07-21
BR9811028A (pt) 2000-08-01
WO1999005144A1 (en) 1999-02-04
IS5352A (is) 2000-01-19
SE9702774D0 (sv) 1997-07-22

Similar Documents

Publication Publication Date Title
PL338181A1 (en) Novel chemical compounds
PL338518A1 (en) Novel compounds
UA66801C2 (uk) Триазоло[4,5-d]піримідинові сполуки, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі та спосіб лікування порушень агрегації тромбоцитів
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
IL114599A0 (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them
IL122855A0 (en) 7H-pyrrolo [2,3-d] pyrimidine derivatives their preparation and pharmaceutical compositions containing them
PL336230A1 (en) Novel chemical compounds
MY118163A (en) Aryl fused azapolycyclic compounds
YU45403A (sh) Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida
SG135965A1 (en) New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
SE9702564D0 (sv) New compounds
IL130538A0 (en) Pyrrolo ¬3,4-d¾pyrimidinone derivatives and their use as medicaments
GEP20033081B (en) Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
SE9702563D0 (sv) Compounds
YU64400A (sh) Aril fuzirana azapoliciklična jedinjenja
TW369529B (en) 5-heterocyclo-1,5-benzodiazepine derivatives, pharmaceutical composition comprising the same and process for the preparation thereof
MY132057A (en) Quinoxalinones, a process for their preparation and their use
SE9802574D0 (sv) Novel compounds
AU2002214467A1 (en) Novel compounds
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)